LEF1 and lung carcinoma: Since si-LEF1-AS1–3 showed the most marked LEF1-AS1 downregulation, si-LEF1-AS1–3 was used as the lead siRNA to suppress LEF1-AS1 expression in lung cancer cells (Fig. 2b).